Latest / Pharmacy Podcast Network / Pharmacy Forward: DSCSA Readiness with PrimeRx and InfiniTrak | Pharmacy Tech Trends: PrimeRx
Transcript
- 0:05Speaker 1: You are listening to the global network of podcasters dedicated
- 0:08Speaker 1: to the pharmacy profession.
- 0:10Speaker 2: Welcome to the Pharmacy podcast Network.
- 0:28Speaker 3: We are committed to the pharmacy owner's success. PRIMRX believes
- 0:32Speaker 3: in empowering pharmacies with innovative solutions to thrive in today's
- 0:36Speaker 3: competitive landscape. We look forward to working with pharmacy owners
- 0:40Speaker 3: and sharing how our solutions can contribute to their sustained
- 0:43Speaker 3: profitability and growth. Connect with us on the web by
- 0:46Speaker 3: going to primarx dot io. That's primearx dot io.
- 0:52Speaker 1: Hey, welcome back to primarx. This is a podcast series
- 0:56Speaker 1: that we have been excited to partner with the primary
- 0:59Speaker 1: X team. I look to that organization a shout out
- 1:02Speaker 1: to Larry Stevenson. Just everything that this organization has done
- 1:10Speaker 1: for the industry, for our independent community pharmacies. We see
- 1:14Speaker 1: them at conferences, we see the investments that they've made
- 1:18Speaker 1: their website. If you don't have an update, prime rx
- 1:22Speaker 1: dot io. Once again, that's prime rx dot io today.
- 1:26Speaker 1: What an exciting time in the in the profession of pharmacy.
- 1:31Speaker 1: Payment is changing, Pharmacies roles are changing. We have collaborative
- 1:37Speaker 1: agreements that are increasing the consultant role of our pharmacists
- 1:41Speaker 1: will continue to grow when you when you talk about that,
- 1:45Speaker 1: we have to talk about technology that supports our clinic
- 1:49Speaker 1: clinical pharmacists, our clinician pharmacists, the independent community pharmacies, and
- 1:55Speaker 1: part of that is making sure that we're compliant and
- 1:58Speaker 1: that we are mitigate the risk of our independent community pharmacies.
- 2:03Speaker 1: Once again, that's an investment that primer x makes into
- 2:06Speaker 1: the core of their partnerships and of their systems. We're
- 2:10Speaker 1: going to be talking about pharmacy forward, the DSCSA readiness
- 2:15Speaker 1: with PRIMARX and Infinite Trac, and really understanding where are
- 2:19Speaker 1: we with the Drug Supply Chain Security Act, the DSCSA
- 2:24Speaker 1: and what that means for our industry. And we bring
- 2:28Speaker 1: experts to these panels. I'm certainly not the expert. That's
- 2:33Speaker 1: why we have these podcasts to gather the people that
- 2:35Speaker 1: know what they're talking about. I would like to introduce
- 2:38Speaker 1: the vice president of Data Analytics and Partnerships with primar X,
- 2:42Speaker 1: Sam Piso. It is so good to see you.
- 2:45Speaker 4: Hey Todd. Good to see you too, and thank you
- 2:48Speaker 4: for putting this together. Excited to be here. It's been
- 2:53Speaker 4: a very busy year. I'm actually going into my sixth
- 2:56Speaker 4: month here at prim X. I'm just excited to be
- 3:00Speaker 4: part of the team as we as we move forward.
- 3:04Speaker 4: I've actually been working with Mark Tadan and Finished Track
- 3:07Speaker 4: for a couple of years now, helping them put together
- 3:11Speaker 4: their processes and procedures as well, and then came over
- 3:15Speaker 4: here at Primary Rights to help in other aspects of
- 3:18Speaker 4: the industry. Just coming off of NCPA and Columbus this
- 3:23Speaker 4: past week, really good to see pharmacies out there learning,
- 3:29Speaker 4: looking at new technology, looking at what needs to be done,
- 3:32Speaker 4: what they need to be doing, talking to other people.
- 3:35Speaker 4: Just kind of still on a little high from that
- 3:38Speaker 4: from being there. So I'm down getting home, getting back
- 3:42Speaker 4: home and just trying to get back into moving forward
- 3:45Speaker 4: and getting some things done.
- 3:48Speaker 1: I agree the month has gone by so quickly. Three
- 3:53Speaker 1: conferences this month for the Pharmacy Podcast Network and I
- 3:57Speaker 1: haven't decompressed yet to the energy in the hope that
- 4:00Speaker 1: was part of the NCPA and the clarity, lots of information,
- 4:06Speaker 1: lots of discussions, and the compliance part in the stop
- 4:10Speaker 1: the start. The shift around d s CSA was one
- 4:14Speaker 1: of my many conversations that were there, and I didn't
- 4:17Speaker 1: have you with me, Sam so I would have liked
- 4:20Speaker 1: to actually have our guest today. The star of our
- 4:23Speaker 1: show today is Mark Tate. He's president of Mark Welcome
- 4:27Speaker 1: to the show.
- 4:29Speaker 2: Hey, thanks, thanks a lot. It's great to be on
- 4:31Speaker 2: the podcast here. It's not our first time. We've been
- 4:37Speaker 2: doing compliance with Drugs Suppled Chain Security Act way back
- 4:41Speaker 2: since twenty sixteen, and we've participated in your podcasts that
- 4:44Speaker 2: are always incredibly valuable and beneficial, and it's really an
- 4:47Speaker 2: honor to be here, and it's great to be on
- 4:51Speaker 2: with Sam. As Sam Sam referenced he's worked with us
- 4:55Speaker 2: as in fit Attraction of Pass and helped us understand
- 4:58Speaker 2: pharmacies to make up great products for dispensers, to make
- 5:03Speaker 2: sure that we were able to work well and help
- 5:06Speaker 2: solve issues. And so it's a real honor to be
- 5:09Speaker 2: on with Sam, who's a good friend. I was also
- 5:14Speaker 2: just at NCPA and we we're very excited to see
- 5:20Speaker 2: the real intense focus on Drug Supply Chain Security Act
- 5:24Speaker 2: and the need to get compliance. As you said, it's
- 5:26Speaker 2: been a kind of a roller coaster ride with Drug
- 5:29Speaker 2: Supply Chain Security Act when it launched in sixteen, and
- 5:33Speaker 2: it delayed and started and people focused on it people
- 5:37Speaker 2: didn't focus on it. Now we're at the real deadline
- 5:40Speaker 2: and people are really focused. We had an enormous amount
- 5:43Speaker 2: of conversations and being up a lot of new customers
- 5:50Speaker 2: there at NCPA, and we were excited to be there.
- 5:55Speaker 2: But I'm very excited to be on this podcast to
- 5:57Speaker 2: talk about where we are talking about some of these exemptions,
- 6:01Speaker 2: talk about what needs to be done for a dispenser
- 6:05Speaker 2: as we approach the November twenty seventh deadline.
- 6:10Speaker 1: November twenty seventh deadline that really stands out to me.
- 6:14Speaker 1: Mark just someone who talks with pharmacy owners weekly in
- 6:20Speaker 1: different sectors, long term care, specialty, community pharmacy. We have
- 6:27Speaker 1: to kind of make the definition first, just in case
- 6:30Speaker 1: we have some listeners that are refreshed, need refreshed, or
- 6:35Speaker 1: don't understand ds CSA. This is a law aimed at
- 6:38Speaker 1: ensuring the integrity and safety of the pharmaceutical supply chain.
- 6:42Speaker 1: Give us an overall definition mark as to the d
- 6:45Speaker 1: s CSA.
- 6:47Speaker 2: Sure, I'd love to do that. So it's really about
- 6:50Speaker 2: patient safety, it really is. It's a law that allows
- 6:54Speaker 2: us to work as a community within the supply chain
- 6:58Speaker 2: to tract drug chain transactions from the manufacturer all the
- 7:02Speaker 2: way to the dispenser, the purpose being to prevent counterfeits
- 7:06Speaker 2: in tampered with drugs or harmful drugs from getting the patients.
- 7:10Speaker 2: It's been a long process to work collaboratively with a
- 7:13Speaker 2: lot of other vendor, third party vendors, wholesalers, manufacturers, third
- 7:18Speaker 2: party logistics partners to be able to track all of
- 7:23Speaker 2: this data ensure the veracity of the product as it
- 7:27Speaker 2: gets to the patient. It's been a little bit of
- 7:31Speaker 2: a left to be able to do it. Fundamentally, what
- 7:34Speaker 2: you need to be able to do is track all
- 7:36Speaker 2: of what we call T three or now we call
- 7:38Speaker 2: T two data, the transaction data of all the drugs
- 7:43Speaker 2: that are shipped from the manufacturer to the wholesaler to
- 7:46Speaker 2: the dispenser. Save that data for at least six years.
- 7:50Speaker 2: You need to be verifying you're authorized training partners to
- 7:55Speaker 2: make sure they're fully licensed so you're not doing business
- 7:58Speaker 2: with bad actors within the supply chain. You need to
- 8:02Speaker 2: be able to identify what we call suspect product or
- 8:05Speaker 2: illegitimate product, identify it, document it reported to the FDA
- 8:09Speaker 2: and or the training partners and boards of pharmacies so
- 8:13Speaker 2: we can get a hold of whether there's bad product
- 8:16Speaker 2: out there, whether it's harmful product out there. And then
- 8:20Speaker 2: now we're moving into the second phase where we're doing
- 8:23Speaker 2: interoperable functions, receiving serialized data so we can track down
- 8:29Speaker 2: to this specific product, we can figure out where problems
- 8:34Speaker 2: are happening in the supply chain, we can prevent counterfeit
- 8:38Speaker 2: being out there. Often when you're talking to pharmacists, they
- 8:44Speaker 2: believe they don't have any or very much suspect product,
- 8:48Speaker 2: but the reality is there's a lot of counterfeit out there.
- 8:51Speaker 2: The biggest latest example is counterfeit ozepic nozepic counterfeit happening
- 8:59Speaker 2: about a month up and a half ago, where a
- 9:03Speaker 2: bad actor stole a serial number, reproduced a serial number
- 9:08Speaker 2: of the product in the product identifier in the data,
- 9:12Speaker 2: reproduced it tens of thousands of times. You got that
- 9:16Speaker 2: product into the market. He tried to sell it to patients.
- 9:20Speaker 2: It was basically it was a counterfeit that they produced,
- 9:24Speaker 2: and it was pharmacists that were able to uncover that counterfeit,
- 9:30Speaker 2: partially through the structure of the supply of the drug
- 9:34Speaker 2: supply Chaine to Carity Act, ultimately protecting patients. Again, there
- 9:38Speaker 2: was another counterfeit earlier on HIV drugs, which were tremendously dangerous,
- 9:44Speaker 2: but they were able to slip that into the supply
- 9:47Speaker 2: chain and it was discovered when patients were not getting
- 9:51Speaker 2: the benefit of the drug that they were supposed to
- 9:53Speaker 2: be And again a pharmacist was able to uncover that
- 9:57Speaker 2: and report that, get an investigation, find a source, and
- 10:00Speaker 2: get it out of the market. So it's you know,
- 10:02Speaker 2: it's a very important, very important regulation for patient safety,
- 10:08Speaker 2: and you're having a little bit of a geek on compliance,
- 10:12Speaker 2: but I'm very excited to be involved in this to
- 10:14Speaker 2: be able to help protect patients, protect healthcare, to make
- 10:19Speaker 2: sure that they're getting good drugs.
- 10:23Speaker 1: Yeah, we are. We are protecting the patients. We're reducing
- 10:26Speaker 1: the chances of counterfeit, tracking and finding the stolen components,
- 10:33Speaker 1: the compounds, the medications. Contaminated drugs entering the US supply
- 10:37Speaker 1: chains a major issue. And you're in this system. The compliancy,
- 10:42Speaker 1: it's going to make it safer and obviously more transparent
- 10:45Speaker 1: that that one that that's time to actually shift the gear,
- 10:49Speaker 1: Sam back to you, and that is why should give
- 10:52Speaker 1: us your insights on how d s c S A
- 10:54Speaker 1: compliance will affect pharmacies in what has become the primary
- 11:01Speaker 1: X major push is to ensure this and what you're
- 11:06Speaker 1: doing to be as compliant as possible and making this
- 11:09Speaker 1: less painful for our pharmacy owners.
- 11:11Speaker 4: Sure sure as we were as I mentioned earlier, I
- 11:16Speaker 4: have worked with him Benetracht for the last couple of
- 11:18Speaker 4: years with Mark the team and whatnot, knowing that the
- 11:25Speaker 4: full implementation of d c s A is going to
- 11:28Speaker 4: affect the pharmacies where additional work is going to need
- 11:31Speaker 4: to be done. So what we've done at primar Racks
- 11:35Speaker 4: and having a clear understanding of the workflow within pharmacies
- 11:39Speaker 4: and what needs to be done is it's important for
- 11:43Speaker 4: pharmacies to understand what they need to be doing. As
- 11:47Speaker 4: an example, the scanning part, so the pieces that Marks
- 11:53Speaker 4: put together and outline about saving data, having an s
- 11:56Speaker 4: ow you know, quarantining or looking for suspect products. That's
- 12:01Speaker 4: in place today. The mandate for those pieces are already
- 12:07Speaker 4: in place. Pharmacies are supposed to be doing that come
- 12:10Speaker 4: November now twenty seventh, a little less than a than
- 12:14Speaker 4: a month. They're going to be responsible for all the
- 12:18Speaker 4: all the pieces and Mark can get into the there's
- 12:22Speaker 4: a couple exceptions still left, so this law has been
- 12:25Speaker 4: a little complicated Convlo Lula, like you you mentioned at
- 12:28Speaker 4: the beginning of the discussion here, but what we did
- 12:32Speaker 4: at Primo X and I think is really one of
- 12:35Speaker 4: the best ways to help pharmacies. You got to remember
- 12:39Speaker 4: the key thing in order to be compliant and find
- 12:42Speaker 4: the track is not in your pharmacy. They can't see
- 12:44Speaker 4: what you're physically getting. What they do see is what
- 12:47Speaker 4: you're ordering on paper, what's going through or what's coming
- 12:50Speaker 4: to you from your supplier. They see all that, but
- 12:53Speaker 4: they can't validate it at the store, and that's where
- 12:57Speaker 4: the pharmacies come in. There's different ways that pharmacies can
- 13:02Speaker 4: account for the product that they receive. There's a number
- 13:06Speaker 4: of different ways that they can do that. But what
- 13:07Speaker 4: we've done with with with our system, our integration with
- 13:11Speaker 4: within Finitract is we lessen that additional scanning piece. So
- 13:15Speaker 4: ideally we can when a pharmacy receives a product they
- 13:21Speaker 4: need to the best way to do it is to
- 13:24Speaker 4: scan it into their system. That way, it's all done
- 13:26Speaker 4: electronically and we can see everything and then and then
- 13:30Speaker 4: if Infinitract see something that's missing, they can alert the
- 13:34Speaker 4: pharmacy that hey, you know you ordered this, but we
- 13:37Speaker 4: didn't see that come in. What we've done is we've
- 13:40Speaker 4: built that into the workflow as well. So when the
- 13:42Speaker 4: pharmacy is actually going through through the through their workflow process,
- 13:48Speaker 4: they scan that bottle. That bottle is sent over to
- 13:50Speaker 4: infinitract to continue to validate that this product was from
- 13:53Speaker 4: this order with that new q R code that all
- 13:57Speaker 4: all products are to have. So the the QR code
- 14:02Speaker 4: that every product has now has not only the lot
- 14:04Speaker 4: of expiration, it also has the G ten and the
- 14:07Speaker 4: serial number. Remember every product out there, every bottle has
- 14:11Speaker 4: its own unique serial number, and that is what's being
- 14:15Speaker 4: that's part of the d CSA law and why have
- 14:19Speaker 4: to make it easier to track a product from the
- 14:22Speaker 4: time it's manufactured to the time it hits the pharmacy
- 14:26Speaker 4: and everyone in between. So it's kind of a big
- 14:28Speaker 4: picture overall view of what we're doing. But the integration
- 14:32Speaker 4: that we have PRIMO QX have created simplifies that process
- 14:37Speaker 4: and minimizes the amount of extra work the pharmacy is
- 14:40Speaker 4: going to need to do to be compliant.
- 14:44Speaker 2: That's right, and Sam brought up a good point that
- 14:47Speaker 2: I didn't really focus on what I spoke before. But
- 14:51Speaker 2: this law was rolled out in two phases. The first
- 14:54Speaker 2: phase what we call lot level tracking in all pharmacies,
- 14:58Speaker 2: all dispensers, all A wholesales, etc. Need to be complying
- 15:04Speaker 2: with a lot of level tracking today before this deadline
- 15:07Speaker 2: in the twenty seven that a lot of level tracking
- 15:10Speaker 2: requires you to be receiving this data today at a
- 15:13Speaker 2: lot level, which is used with an EDI transaction. A
- 15:19Speaker 2: lot of level tracking started in twenty sixteen and everybody
- 15:24Speaker 2: should be receiving that. They need to have a SOP
- 15:28Speaker 2: describing how they're complying with the law, and they need
- 15:33Speaker 2: to be checking their trading partners licensing to make sure
- 15:37Speaker 2: they're not working with bad actors. As we move into
- 15:40Speaker 2: the second phase, we're going from a lot level tracking
- 15:44Speaker 2: to product level tracking. Now that means we're gathering serial
- 15:47Speaker 2: numbers for every single saleable unit in your pharmacy, which
- 15:51Speaker 2: is an enormous amount of data. It required a different
- 15:54Speaker 2: kind of data protocol, which we call EPSYS and it's
- 15:58Speaker 2: all the epscess data protocol is also an interoperable protocol
- 16:02Speaker 2: which allows you to communicate back into the supply chain
- 16:05Speaker 2: to do things like product verification if you do get
- 16:08Speaker 2: a product that may be suspect.
- 16:12Speaker 5: And as we you know, that's kind of a confusing
- 16:16Speaker 5: description to pharmacists as they're doing all the heavy lifting
- 16:20Speaker 5: for all the other compliance issues within their pharmacy.
- 16:24Speaker 2: Often the question we got is, you're telling me you're
- 16:28Speaker 2: gonna we're gonna have to do this this check in
- 16:31Speaker 2: process twice. We're gonna have to scan products twice. We're
- 16:34Speaker 2: gonna have to make sure we were receiving this this workflow,
- 16:38Speaker 2: receiving multiple times within our pharmacy. We're already overwhelmed. And
- 16:43Speaker 2: this integration with with Micrommersion understands that pharmacy's present burden
- 16:50Speaker 2: and actually makes it so that there's not additional workflow
- 16:54Speaker 2: from what they were doing before because the way I
- 16:57Speaker 2: understand it, but Sam, but they're using actions that have
- 17:02Speaker 2: already happened in their workflow and integrating our platform with THEIRS,
- 17:06Speaker 2: with the data to make sure that the proper checks
- 17:09Speaker 2: and balances are happening with the Drug Supplies and Security
- 17:12Speaker 2: Act data so that they don't actually have an added
- 17:15Speaker 2: workflow to be compliant, but they get to full compliance package.
- 17:20Speaker 2: And as Sam referenced, we put these real time alerts
- 17:24Speaker 2: to advise them directly if there's a conflict or a
- 17:27Speaker 2: problem with a drug or a license. That way, they
- 17:30Speaker 2: they live in their primary X platform. We exist behind
- 17:36Speaker 2: the scenes. We don't add to their workflow, but we
- 17:40Speaker 2: achieve full compliance and protect the patients as a result.
- 17:47Speaker 4: Jackie mark and and to and to add to that
- 17:49Speaker 4: d D the the end. The the double scanning is
- 17:55Speaker 4: the key piece. So if Primer actually done something unique
- 18:00Speaker 4: that I don't know if anyone else does it, and
- 18:02Speaker 4: that is the way we're taking that serial number or
- 18:05Speaker 4: that scan in within workflow. That eliminates the need for
- 18:09Speaker 4: a pharmacy to have to double scan or scan a
- 18:11Speaker 4: product twice when they receive it once for their inventory ones.
- 18:15Speaker 4: For the Infinite Tract system, the integration helps to do
- 18:19Speaker 4: that and it creates a what I consider a double
- 18:24Speaker 4: check on that product. So for pharmacies that do scan
- 18:28Speaker 4: product in Primo X is going to see that anyway
- 18:31Speaker 4: and we can send that over to to to the
- 18:35Speaker 4: Infinite Track system. But also when we double check it
- 18:38Speaker 4: during workflow, that goes back to revalidate to to Infinite
- 18:43Speaker 4: Tract that the product is in fact it what was
- 18:47Speaker 4: ordered is what was received from that standpoint.
- 18:51Speaker 2: Absolutely, it is a really it's a it's a very impressive,
- 18:54Speaker 2: smooth system that Primary X customers are able to is
- 19:00Speaker 2: and like I said, get full compliance and not add
- 19:03Speaker 2: to their workflow, which is a very important point for
- 19:07Speaker 2: I hear from pharmacists on a regular.
- 19:09Speaker 4: Basis, exactly, and so the fact that the alerts that
- 19:12Speaker 4: you mentioned mark it's unique because of pharmacists in order
- 19:16Speaker 4: to check or the pharmacy in order to check to
- 19:18Speaker 4: make sure everything's correct, they'll have to go into their
- 19:21Speaker 4: system or into the Infinite Tract portal to look for,
- 19:24Speaker 4: oh did disorder come in? Okay, did this come in?
- 19:27Speaker 4: Find what have you it? Basically, the system alerts the
- 19:33Speaker 4: pharmacy that hey, you ordered this, but actually we haven't
- 19:37Speaker 4: seen it, or we didn't see this, or it's not correct.
- 19:40Speaker 4: We alert the pharmacy. So it's called the action basically
- 19:42Speaker 4: letting the pharmacy know, hey, something's not right with that order,
- 19:46Speaker 4: with that product, and then they can start investigating at
- 19:48Speaker 4: that point.
- 19:49Speaker 2: Absolutely, and the kind of refrain I would hear when
- 19:52Speaker 2: we were first marketing the product was oh no, not
- 19:57Speaker 2: another portal. I have decided to farm assists you know,
- 20:01Speaker 2: the many different portals that they have to use in
- 20:04Speaker 2: order to do their daily business. So this integration really
- 20:08Speaker 2: helps reduce that for the pharmacy. It's exciting. It's exciting
- 20:13Speaker 2: for me.
- 20:14Speaker 1: So the simplicity and the assurance that I have a
- 20:21Speaker 1: technology company, my pharmacy system that is tied into this,
- 20:25Speaker 1: it really puts me at ease. If I was thinking
- 20:27Speaker 1: of if I was an owner, it's I don't want
- 20:30Speaker 1: to think about so many of these things when I
- 20:32Speaker 1: have employees, have you know, the audits, and I have
- 20:36Speaker 1: things going on, and obviously my patients and my community
- 20:38Speaker 1: is the most important thing. And now primary accident infinitracts
- 20:43Speaker 1: bringing something to the table that just just brings seamlessness
- 20:47Speaker 1: to it. So this is good to hear.
- 20:50Speaker 4: There's a lot of I'm sorry, Mark, there's a lot
- 20:53Speaker 4: of confusion out there, Todd and what they need to
- 20:55Speaker 4: be doing with the pharmacy needs to do. And then
- 20:58Speaker 4: when you hear about the delays, and Mark, you may
- 21:01Speaker 4: want to touch on this. When you hear about the delays,
- 21:04Speaker 4: they're like, oh, we don't have to do anything until
- 21:06Speaker 4: you know, another year or what have you. There's a
- 21:09Speaker 4: new a new delay that affects a certain portion of
- 21:14Speaker 4: the pharmacy, and you can explain that a little better.
- 21:16Speaker 4: But remember there are procedures that you need to be
- 21:20Speaker 4: doing today, So there are aspects of the first phase
- 21:24Speaker 4: is in place today, So mark go ahead.
- 21:27Speaker 2: Yeah, So there is there's a term we call we's
- 21:32Speaker 2: in the industry, which are is an abbreviation for three
- 21:36Speaker 2: categories of what we loosely call delays, which are really
- 21:40Speaker 2: are delays. There's waivers, exemptions, and exceptions. But the recently
- 21:47Speaker 2: there there was an exemption letter sent out for pharmacies
- 21:52Speaker 2: which which gave a delay for interoperability for pharmacies with
- 21:59Speaker 2: twenty five less full time pharmacists and farm techts. This
- 22:04Speaker 2: was a delay of recognizing that the full data stream
- 22:09Speaker 2: wasn't up and running. They weren't able to set all
- 22:12Speaker 2: the serialized data yet. This happened about a couple of
- 22:15Speaker 2: months ago, and that delay gave pharmacies the ability to
- 22:23Speaker 2: wait a little bit extra time to the serialized part
- 22:27Speaker 2: of the law fully compliant. However, the first phase that
- 22:31Speaker 2: we talked about before receiving the data, authorizing your partners,
- 22:38Speaker 2: finding suspect product, reporting suspect product still in full force.
- 22:44Speaker 2: So It's a little bit confusing when we use the
- 22:46Speaker 2: word delay, because there wasn't really a delay of the law.
- 22:50Speaker 2: It was just an exemption of some of the requirements
- 22:56Speaker 2: as per serialization. Then we had just recently last month,
- 23:03Speaker 2: I'm sorry, not last month, this month October ninth, a
- 23:06Speaker 2: further exemption for all stakeholders in the supply chain that
- 23:12Speaker 2: said that if you're eligible that eligible for this exemption,
- 23:19Speaker 2: you and you receive a product without full serialization, you
- 23:25Speaker 2: will have an exemption. But the eligibility is what the
- 23:28Speaker 2: key is there. The eligibility is that you're fully connected
- 23:31Speaker 2: to your training partners receiving all of the data for
- 23:35Speaker 2: all the compliance data, and that you are making documented
- 23:40Speaker 2: efforts to get serialized data from all your trading partners
- 23:45Speaker 2: and or if you're a manufacturer, to send it send
- 23:47Speaker 2: that data. So that's a big Those are big eligibility
- 23:52Speaker 2: items because it means you have to be on a system,
- 23:54Speaker 2: you have to be compliant with at least a first
- 23:56Speaker 2: phase today in order to get this exemption on some
- 24:00Speaker 2: of the serialized product that are some of the non
- 24:04Speaker 2: serialized products that will come through the supply chain. And
- 24:08Speaker 2: this exemption, which I think is actually a really good exemption,
- 24:13Speaker 2: except for the fact that it's being interpreted as a delay,
- 24:16Speaker 2: but I'll address that in the second. But this exemption
- 24:19Speaker 2: is staggered, so manufacturers have until May to use this exemption.
- 24:26Speaker 2: Wholesalers have until August of twenty twenty five to use
- 24:30Speaker 2: this exemption, and dispensers have until November twenty seventh to
- 24:35Speaker 2: use this exemption. So they staggered it recognizing that in
- 24:38Speaker 2: order to ensure serialized data is out there, May the
- 24:41Speaker 2: factors have to be doing it one hundred percent, So
- 24:44Speaker 2: their deadline with this exemption is in May. And then
- 24:48Speaker 2: in order for a dispenser to further get the right
- 24:51Speaker 2: serialized data, the wholesalers have to be fully one hundred
- 24:54Speaker 2: percent serialized, So theirs is in August, and then we
- 24:58Speaker 2: move into November for dispensers. But it's important to understand
- 25:01Speaker 2: that it's really not a delay. The laws fully in place,
- 25:06Speaker 2: and what these exemptions really say is this is what
- 25:10Speaker 2: the intent of the FDA is on enforcement. They're going
- 25:14Speaker 2: to give you some leeway on serialized data if you're
- 25:18Speaker 2: not receiving it from your training partners. As long as
- 25:21Speaker 2: you're receiving data and you're making documented efforts to make
- 25:25Speaker 2: sure you're receiving serialized data, then you'll have you have
- 25:29Speaker 2: an exemption on that one part, which is really a
- 25:33Speaker 2: product level exemption for those products that aren't serialized. It
- 25:37Speaker 2: was there was a lot of panic out there because
- 25:41Speaker 2: we knew that some wholesalers or manufacturers are not going
- 25:45Speaker 2: to be able to send all serialized data on the
- 25:48Speaker 2: deadline that's coming up in about three weeks, and we
- 25:52Speaker 2: didn't know exactly how we're going to handle that. So
- 25:54Speaker 2: this last exemption was received very well by the entire industry,
- 25:59Speaker 2: I believe, but it's important people understand that it doesn't
- 26:04Speaker 2: mean you can't don't have to do anything until next year.
- 26:07Speaker 2: It doesn't mean you don't have to do anything until
- 26:09Speaker 2: twenty twenty six. It just narrows down the scope a
- 26:12Speaker 2: little bit, gives you a little bit more runway. It
- 26:15Speaker 2: allows the manufacturers and the wholesalers to refine their systems
- 26:21Speaker 2: and get you the serialized data. And once this is done,
- 26:24Speaker 2: it's going to be a great improvement for patient safety
- 26:27Speaker 2: within the supply chain that we should all be proud of.
- 26:34Speaker 4: So just to kind of change something, move move a
- 26:38Speaker 4: little in a little different direction. I do want to
- 26:40Speaker 4: address on one area that is still an issue today
- 26:44Speaker 4: as it's been since since the law was enacted, and
- 26:48Speaker 4: that is pharmacies that don't understand why they need to
- 26:53Speaker 4: use a service when they can do it themselves. Or
- 26:57Speaker 4: the biggest misnomer is well, my wholesaler's got me cut.
- 27:00Speaker 4: They have a portal they're keeping track of all that data.
- 27:03Speaker 4: That is exactly correct, that's one hundred percent correct. So
- 27:06Speaker 4: if you're buying from your primary they all have a
- 27:10Speaker 4: portal where you can go in and see what you purchased.
- 27:15Speaker 4: That's all they do. Now, keep in mind, if you're
- 27:17Speaker 4: purchasing from multiple wholesalers, which everybody does and you know
- 27:22Speaker 4: for the most part, then every one of your wholesalers
- 27:26Speaker 4: need to provide you with that portal for you to
- 27:28Speaker 4: have access to. So if you're audited, now you've got
- 27:31Speaker 4: to go to five or six different wholesalers. Some may
- 27:34Speaker 4: have a portal, the bigger guys do, the smaller guys
- 27:37Speaker 4: may not, So you're not going to that data is
- 27:39Speaker 4: not going to be at your at your disposal as
- 27:42Speaker 4: quickly and the mark what is at forty eight hours
- 27:44Speaker 4: you're given to.
- 27:45Speaker 2: Forty eight hours you're given to produced data. So if
- 27:48Speaker 2: an inspector comes in and asks you for a certain
- 27:51Speaker 2: set of data, maybe a date range or an NDC
- 27:54Speaker 2: level or EIVE a wholesaler level, you're giving forty eight
- 27:59Speaker 2: hours to produce that data. And if you have all
- 28:01Speaker 2: that data and a bunch of other portals and you
- 28:05Speaker 2: need help to get that data out of the portals,
- 28:07Speaker 2: which is going to be likely, then you may not
- 28:12Speaker 2: probably will not make that forty eight hour deadline. In
- 28:15Speaker 2: addition to that that those portals give kind of a
- 28:18Speaker 2: false sense of confidence that you're complying using those portals.
- 28:23Speaker 2: All those portals are really doing is providing a repository
- 28:26Speaker 2: for that data. It's not checking the licenses. You need
- 28:29Speaker 2: to be checking licenses. It is a responsibility of the
- 28:34Speaker 2: dispenser to make sure everybody's license is good. You need
- 28:37Speaker 2: to have documented that you did it. Now you know
- 28:40Speaker 2: you The response will be to, well, why would Cardinal's
- 28:44Speaker 2: license not be good? Right, but you still need to
- 28:47Speaker 2: be doing it. It's a requirement of the law. And
- 28:50Speaker 2: then the second piece is identifying suspect product. So if
- 28:55Speaker 2: what you're doing is receiving the data in the portal
- 28:58Speaker 2: and it's saving there, you're comfortable doing that, you're not
- 29:00Speaker 2: really viewing the data right, so you're not aware if
- 29:04Speaker 2: the data is missing components, or you may not catch
- 29:10Speaker 2: a suspect product that you're required to catch, investigate and
- 29:14Speaker 2: report because that data is not in the portal in
- 29:16Speaker 2: front of you. It is not that in that dashboard
- 29:19Speaker 2: in front of you. So while you can do it
- 29:22Speaker 2: with with the with the portals, and you can do
- 29:25Speaker 2: some of these other tasks manually, like checking licenses, it's
- 29:29Speaker 2: well worth the cost of the system to have it
- 29:33Speaker 2: all in one dashboard. And furthermore, if it's integrated into
- 29:37Speaker 2: your pharmacy management system, which you're you're already using and
- 29:41Speaker 2: dependent on, then it makes the whole process much easier
- 29:44Speaker 2: and much more automated. I also wanted to mention about
- 29:47Speaker 2: that automated. We make great efforts to make sure this
- 29:49Speaker 2: process is automated, but we don't just walk away from
- 29:53Speaker 2: the customer after that. We have a very robust customer
- 29:56Speaker 2: service and regulatory expert staff that's always on call interacting
- 30:01Speaker 2: with the customer to make sure that this process is
- 30:03Speaker 2: easy for them. We we don't just give you the
- 30:07Speaker 2: tools and leave you alone where they're to help you
- 30:09Speaker 2: on every step of the process.
- 30:15Speaker 1: All right, So I'm gonna kick things back to Sam
- 30:18Speaker 1: just as a shout out to listeners for people. For
- 30:24Speaker 1: pharmacy owners that are using primar X, there's less risk
- 30:29Speaker 1: because you already have something that you can build in
- 30:31Speaker 1: and and that's terrific. Can you give some advice to
- 30:35Speaker 1: our to other pharmacy owners who might not be Primary
- 30:40Speaker 1: X customers as to maybe how to make the assessment
- 30:46Speaker 1: about their own system and maybe what's the what's the
- 30:50Speaker 1: next phase for them to to have an environment that
- 30:54Speaker 1: makes things this seamless.
- 30:56Speaker 4: So for non primary X users, depending on a lot
- 31:02Speaker 4: of it is what are their PMS vendor doing? Are
- 31:07Speaker 4: they are they supporting the s c s A, do
- 31:09Speaker 4: they provide the tools? How how is that being done?
- 31:13Speaker 4: One of the biggest issues that the pharmacies will have,
- 31:16Speaker 4: it's been my experience with non primary X users is handling.
- 31:21Speaker 4: You know, you've got to be prepared to handle the
- 31:24Speaker 4: additional workflow that's going to be required for product intake
- 31:29Speaker 4: when you receive your product. If you're not currently standing
- 31:33Speaker 4: that in into your system, then the challenge will be
- 31:39Speaker 4: that that that you're not compliant. You don't know if
- 31:41Speaker 4: what you ordered is is impact what you received. It
- 31:44Speaker 4: could be just as simple as The thing to keep
- 31:46Speaker 4: in mind is having you know a serial number. It's
- 31:49Speaker 4: almost impossible to do it manually. You need scanning is
- 31:54Speaker 4: and the law does not require you to scan, but
- 31:58Speaker 4: it is the most efficient and accurate way to bring
- 32:03Speaker 4: in product. To me, that's going to be the biggest
- 32:05Speaker 4: The biggest piece you've got to prepare for is the
- 32:07Speaker 4: additional workload and making sure that you have your your
- 32:12Speaker 4: s o w's r s OP in places for you know,
- 32:15Speaker 4: and that's when an inspector comes in. That's one thing
- 32:17Speaker 4: that the first thing you're going to ask for is
- 32:20Speaker 4: what's your standard operating procedure for suspect or legitimate products?
- 32:24Speaker 4: What you do when you receive something that's questionable, where's
- 32:27Speaker 4: your quarantine area? How are you handling? Do you put
- 32:30Speaker 4: it off to the side? You know, So those are
- 32:32Speaker 4: things you've got to justify and need to have be
- 32:35Speaker 4: prepared for. We you know, through inventit tract. Of course
- 32:39Speaker 4: we do have all those pieces available and they have them,
- 32:43Speaker 4: but if you're not on obviously for the non primur X,
- 32:47Speaker 4: make sure you have those those pieces in place. It's
- 32:50Speaker 4: very important you come in and when you when you
- 32:53Speaker 4: get inspected, When an inspection takes place, it is being
- 32:57Speaker 4: prepared to The first thing is going to be show
- 33:00Speaker 4: me what you do, and then the next would be okay,
- 33:03Speaker 4: they'll say they could take a product off the shelf
- 33:05Speaker 4: and say give me the serialized information attracting information for
- 33:08Speaker 4: this product. So those are the type of things to
- 33:11Speaker 4: be prepared for on that we're pushing to our customers
- 33:16Speaker 4: that they that they need to be compliant by the
- 33:19Speaker 4: end of this by the twenty seventh. For those the pharmacies,
- 33:22Speaker 4: I think that they're they're they're safe. Make sure you
- 33:25Speaker 4: know you understand the law and understand what you need
- 33:28Speaker 4: to be doing. That to me, that's the biggest piece.
- 33:31Speaker 2: Yeah, And I'll say when you're comparing other options, making
- 33:36Speaker 2: sure you have that data flow and it's continuous. Well,
- 33:39Speaker 2: what we found is that sometimes the vendors connection breaks
- 33:45Speaker 2: and if you're not paying attention to that data flow,
- 33:49Speaker 2: then you may be in a position where you don't
- 33:52Speaker 2: know that you're not receiving the data and then if
- 33:55Speaker 2: the inspector comes and asks you for serialized or for
- 33:59Speaker 2: complain data for a certain item, which they may do
- 34:02Speaker 2: just pick it off the shelf. You may discover at
- 34:04Speaker 2: that point you don't have that, you don't have that
- 34:07Speaker 2: data flow coming into your system. One of the things
- 34:10Speaker 2: we do is we give you an alert. If if
- 34:13Speaker 2: you're a cardinal customer, then all of a sudden you're
- 34:15Speaker 2: not getting any cardinal transactions. We're going to give you
- 34:17Speaker 2: an alert that says you know, you haven't received a
- 34:20Speaker 2: cardinal transaction for this time period, which will give you
- 34:24Speaker 2: an alert that maybe there's a problem with the data flow
- 34:26Speaker 2: and our system will detect it. Also, it's also important
- 34:30Speaker 2: that there's an issue with well, we talked about exceptions
- 34:34Speaker 2: in the industry, but with drug supply chain security. Yet
- 34:38Speaker 2: an exception can be you receive a product without data
- 34:44Speaker 2: or a data or data without a product. So if
- 34:48Speaker 2: you get a mispick from your wholesaler where they put
- 34:52Speaker 2: something in your toe that does not belong there, you
- 34:55Speaker 2: didn't order, probably didn't pay for it. That's what we
- 34:58Speaker 2: call an exception. And if you're going to put that
- 35:01Speaker 2: on yourself, you need to make sure you have that
- 35:03Speaker 2: data with that product. Now, if you're depending on a portal,
- 35:07Speaker 2: you're not going to know you got to you're not
- 35:09Speaker 2: going to be aware of that misspit because you're not
- 35:11Speaker 2: seeing that compliance data. It's important you're able to deal
- 35:15Speaker 2: with these exceptions and you have a partner that will
- 35:18Speaker 2: alert you to the exceptions and help you solve that
- 35:23Speaker 2: exception with the right kind of exception reporting. With the
- 35:28Speaker 2: integration with primer X, we have these real time alerts
- 35:32Speaker 2: tell you if you have an exception, and then we
- 35:35Speaker 2: process it with a report to make sure you're fully compliant.
- 35:39Speaker 2: But there's a lot of little things out there that
- 35:42Speaker 2: you need to pay attention to and understand the law
- 35:44Speaker 2: to make sure you're fully compliant. So it's important to
- 35:48Speaker 2: have a partner that will help educate you in that process.
- 35:51Speaker 1: Also excellent, excellent, Thank you both. Mark, This has been
- 35:58Speaker 1: terrific to talk with you and catch up with the
- 36:00Speaker 1: Infinite Track team. Thank you for being part of this
- 36:03Speaker 1: podcast episode. Sam, we have to meet up more often
- 36:06Speaker 1: than maybe once or twice a year. I think the
- 36:09Speaker 1: X conference I'm going to that we saw you at
- 36:11Speaker 1: last year was a Sembia, so maybe we'll actually find
- 36:14Speaker 1: some time to talk there about how Primarxes is in
- 36:18Speaker 1: the specialty pharmacy market as well.
- 36:22Speaker 4: I will see you there, Todd. For sure, I'll be there.
- 36:25Speaker 1: Excellent. Hey, if you're a pharmacy owner you're concerned with this,
- 36:28Speaker 1: if you're a pharmacy technician that runs the compliancy division
- 36:32Speaker 1: of your pharmacy, do not fear. There's lots of guidance
- 36:36Speaker 1: out there. Reach out to Primearx, go to primarx dot io,
- 36:41Speaker 1: or even take a look at the infinitrek site which
- 36:44Speaker 1: is in a infinitrec dot us. Once again, that's Infinity
- 36:49Speaker 1: dot us, Mark Sam. This has been special. Appreciate you
- 36:53Speaker 1: sharing with us and our listeners.
- 36:56Speaker 2: Thank you, Todd, Thank you very much.
- 37:01Speaker 3: Data at PA return to UPLOA